Y-mAbs Therapeutics
YMAB
#6603
Rank
NZ$0.88 B
Marketcap
$19.81
Share price
-12.06%
Change (1 day)
138.79%
Change (1 year)

Y-mAbs Therapeutics (YMAB) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$83.23 Million

According to Y-mAbs Therapeutics 's latest financial reports the company's total liabilities are NZ$83.23 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Y-mAbs Therapeutics - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$42.51 M-16.27%
2022-12-31NZ$50.77 M6.13%
2021-12-31NZ$47.84 M31.7%
2020-12-31NZ$36.32 M40.1%
2019-12-31NZ$25.92 M52.61%
2018-12-31NZ$16.99 M20.97%
2017-12-31NZ$14.04 M87.1%
2016-12-31NZ$7.5 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$45.3 M-45.57%๐Ÿ‡บ๐Ÿ‡ธ USA